Daré Bioscience held its earnings call for the first quarter of 2026 on May 14 to discuss financial results and business updates focused on women's health products.
Daré Bioscience, Inc. hosted the conference call at 4:30 PM EDT to cover results for the quarter ended March 31, 2026. Chief Accounting Officer MarDee Haring-Layton opened the session and introduced CEO Sabrina Johnson as the main participant alongside her.
Cytek Biosciences released its financial results for the first quarter of 2026 on May 7. The company then hosted an earnings conference call the same day at 4:30 PM EDT.
Сообщено ИИ
BioMarin Pharmaceutical Inc. conducted its first-quarter 2026 earnings conference call on May 4, 2026. Company executives, including CEO Alexander Hardy, presented financial results and updates. The call included forward-looking statements and non-GAAP measures.
ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.
Сообщено ИИ
PureCycle Technologies conducted its first quarter 2026 corporate update conference call on May 6. The session featured the company's top executives reviewing recent developments.